Been digging through some interesting sub-$5 plays lately, and there's actually a solid group of these penny stocks that caught my attention - all carrying A-ratings from the Portfolio Grader. Worth looking at if you're trying to diversify without going too mainstream.

So here's the thing about penny stocks - everyone talks about the risk, but honestly, if you're selective, there are some real opportunities. The ones worth your time get graded on earnings performance, growth trajectory, analyst sentiment and buying momentum. That screening process weeds out a lot of the noise.

Lexaria Bioscience is doing something genuinely interesting in the biotech space. Their DehydraTECH platform is basically a drug delivery system that makes medications absorb faster and taste better - no more sugar-loaded tablets. They had $4.7 million cash on hand and pulled in $145k in revenue last quarter, which is up significantly from prior year. Still losing money but the burn rate is dropping. Stock's up massive this year.

JanOne is another biotech angle, but with a crypto twist. They're working on non-addictive pain treatments - their lead candidate for peripheral artery disease just cleared Phase 2A. But here's the kicker: they own a fintech subsidiary processing hundreds of millions in crypto transactions. So you're essentially getting biotech exposure plus a play on blockchain infrastructure. That dual angle is pretty unique for a penny stock.

Ocugen's a Pennsylvania biotech working on gene therapies for eye diseases. They're joining the Russell 3000 soon, which means institutional money will start flowing in through index funds. Early-stage biotech always has losses, but their per-share loss is actually improving. The Russell inclusion could be a real catalyst.

Kuke Music is a Chinese digital music company - classical music licensing, smart pianos, that kind of thing. They just partnered with an AI music tech company to launch something through automotive software platforms. 2023 was rough financially, but that AI partnership could be the turnaround play.

Jin Medical makes wheelchairs and mobility products in China. They did a 20-for-1 stock split which tanked the price, but their financials are solid - revenue growing, profits improving. The stock's been beaten down but the fundamentals suggest a rebound could be coming.

Caravelle International has a patent-pending process that uses ship exhaust heat to dry lumber during transport. Sounds niche, but it's genuinely innovative - they're already working with governments in Africa. If they can scale this, it's a real environmental play with commercial potential.

Eco Wave Power converts ocean wave energy into electricity. They're operational in multiple countries already, though no revenue yet. The infrastructure is there, just waiting for commercialization to kick in.

Obviously penny stocks carry real risk - these companies are smaller, less liquid, and things can move fast in either direction. But if you do your homework and stick to the ones with solid fundamentals and real technology or business models, you can find some interesting opportunities. The key is not chasing them blindly - look at cash position, burn rate, and what's actually differentiating them in their market.

If you're going to explore penny stocks, at least start with ones that have some substance behind them rather than pure speculation. These seven have actual products, real revenue or clear paths to it, and analyst backing. Not a guarantee of anything, but better odds than most of what's out there in this category.